Affinity maturation and light-chain-mediated paratope diversification anticipates viral evolution.

Summary

Using antibodies from infection-naive vaccinees, the authors show that hallmark heavy-chain mutations in IGHV3-53/66 generate an affinity buffer against conserved RBD residues, while alternative light-chain pairings diversify paratopes to accommodate Omicron mutations. This cooperative mechanism explains how vaccination can endow anticipatory breadth against future variants.

Key Findings

• IGHV3-53/66 antibodies from infection-naive vaccinees frequently neutralize Omicron and harbor hallmark breadth-enhancing heavy-chain mutations.
• Omicron breakthrough infection altered Ig light-chain pairing frequencies without changing IGHV3-53/66 mutation frequencies, indicating selection for favorable pairings.
• Structural analyses show heavy-chain mutations optimize contacts with conserved RBD residues, while alternative light chains rewire interactions at Omicron mutation sites, yielding cooperative anticipatory breadth.

Clinical Implications

Guides next-generation vaccine strategies: focus on functionally constrained RBD epitopes, promote affinity maturation, and engineer or select for favorable light-chain pairings to enhance breadth against evolving SARS-CoV-2 variants.

Limitations

• Focus on a single antibody germline family (IGHV3-53/66) may limit generalizability across broader repertoires
• Observational/mechanistic study without clinical efficacy endpoints

Future Directions

Translate the cooperative breadth model into immunogen design and clinical trials, testing light-chain–focused strategies (e.g., mosaic or guided pairing) to broaden protection against emerging variants.